causing epidemics every year, globally. [2] In 2009, a novel infl uenza virus (H1N1) pdm09 emerged, with at least 18,449 deaths reported by August 2010. [3] While A (H1N1) pdm09 is no longer a pandemic virus, however, A (H1N1) pdm09 continues to circulate widely and has become part of seasonal H1N1 virus. [4] In India, the fi rst confi rmed case of pandemic infl uenza A (H1N1) was reported in Hyderabad on 16 May 2009 [5] and by July 2010, a total of 34,669 laboratory-confi rmed cases including 1692 deaths were reported.
Introduction
Infl uenza viruses cause frequent epidemics and periodic pandemics, and are a major public health problem. Globally, infl uenza is responsible for 250,000-500,000 deaths annually. [1] Presently, H1N1, H3N2 sub-type of infl uenza type A and type B infl uenza viruses are circulating and received, the mandatory rapid virus identifi cation cannot be done through culture procedures as it is time consuming. Infl uenza virus sub-typing is a critical tool in making therapeutic and infection control decisions. Virus isolation and characterisation by hemagglutination inhibition (HI) in these situations is time consuming. Molecular techniques such as conventional and real time RT-PCR provide the rapidity and enhanced sensitivity for detection and typing and sub-typing of infl uenza viruses. However, in resource limited countries real-time RT-PCR cannot be used by many peripheral laboratories because of the high cost. Further with the emergence of pdm09 viruses in 2009 the need for an early and accurate diagnosis for pandemic infl uenza became important for epidemiological and therapeutic purposes. Thus we have developed and evaluated an in-house multiplex RT-PCR and compared it with virus isolation for detection and characterisation of infl uenza viruses including pandemic A (H1N1) pdm09 in this study.
Materials and Methods
The study was conducted from June 2007 to January 2009 and then from September to November 2009. During this period, 1567 nasal and throat swab samples were collected from patients of all ages with infl uenza-like illness (ILI) and their clinical details were recorded. Of these, 544 samples were selected randomly for the present study. ILI was defi ned as fever (≥100°F) or history of fever accompanied with cough and/or sore throat. Written consent was obtained from all patients at the time of sample collection and the study was approved by the Institutional Ethics Committee of All India Institute of Medical Sciences, New Delhi (letter no IEC/P-23/04.01.2010).
Samples were transported in 3 ml of viral transport medium (VTM) to the virology laboratory at 4°C. Specimens were processed in biosafety level II cabinet, and divided into three aliquots. The fi rst aliquot was used for virus isolation in cell culture, the second was used for RT-PCR and the third was stored at −80°C deep freezer as a backup.
Virus isolation
Infl uenza viruses were isolated in Madin-Darby Canine Kidney (MDCK) cells, provided by National Institute of Virology (NIV), Pune and maintained in Dulbecco's Modifi ed Eagle medium supplemented with 10% foetal calf serum (Gibco), 1% L-glutamine (Sigma, USA), 100 IU/ml penicillin (Sigma, USA), 100 mg/ml streptomycin (Hi Media, India). The cells were seeded onto T-25 fl ask (Corning Incorporated, NY, USA) either 24 or 48 h prior to sample inoculation at 35°C in presence of 5% CO 2 . The processed samples were inoculated (400 μl) on to monolayers of MDCK cells. The inoculum was allowed to adsorb for 30 min at 37°C, followed by addition of 5 ml of serum-free virus growth medium with 2 μg/ml trypsin (Sigma, USA) to each fl ask. The fl asks were again incubated at 35°C with 5% CO 2 . Cell culture was observed daily for cytopathic effect (CPE). Cells were harvested either when 3+ or 4+ CPE was observed or on 7 th day even if no CPE was observed. Presence of infl uenza virus was confi rmed by hemagglutination assay (HA) using 0.75% guinea pig red blood cells and sub-typing was done by hemagglutination inhibition assay (HI) using reference antisera provided by World Health Organisation (WHO) collaborative centre for infl uenza viruses at Centre for Disease Control and Prevention (CDC) Atlanta, USA.
Reverse transcription polymerase chain reaction
RNA extraction was done using 350 μl of sample with the RNeasy Mini kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions. Infl uenza virus cDNA was synthesised using random primer (Promega Corps., USA) and avian myeloblastic reverse transcriptase (AMV RT), (Promega Corp. USA). For 12.5 μl reaction volume, 5.0 μl of RNA and 500 ng of random primer along with 200 μM of each deoxynucleotise triphosphates (dNTPs) (Promega, Corps., USA) and 10 units of AMV RT were used. The reaction mix was incubated at 37°C for 90 min, followed by 65°C for 10 min to inactivate the enzyme.
Primers
Primers used for detection and typing of infl uenza virus targeted amplifi cation of matrix and non-structural gene (NS) for infl uenza A and infl uenza B, respectively, and sub-typing of seasonal infl uenza A into A/H1N1, A/H3N2 used specifi c primers from hemagglutinin gene (HA) and neuraminidase gene (NA) [ Table 1 ]. [8] New set of the typing primer (type A/Mat-II) from matrix gene and sub-typing primer from HA gene for infl uenza A were used on samples collected after July 2009 as pandemic A (H1N1) pdm09 viruses were not detected by the earlier primers [ Table 1 ]. [9] Typing PCR Typing PCR for infl uenza A and B was carried out as a monoplex assay with 5 μl of cDNA in a total volume of 25 μl containing 50 picomoles each of forward and reverse primers of infl uenza A or infl uenza B, 200 μM each of four dNTPs, and 1.5 units of the Taq polymerase (Bangalore Genei, India). DNA amplifi cation was performed using an initial denaturation for 3 min at 94°C, followed by 35 cycles of denaturation for 1 min at 94°C, annealing for 1 min at 52°C and extension for 1 min at 72°C, with fi nal extension for 10 min at 72°C in a thermo cycler (Gene AMP PCR system 9700, Applied Biosystems, USA). Amplicons of 311 for infl uenza A [ Figure 1b and c] and 108 bp for infl uenza B [ Figure 1a ] were visualised under a digital gel documentation system (Bio-Rad, UK). PCR mix for multiplex RT-PCR for pandemic A (H1N1) pdm09 infl uenza viruses contained 20 picomoles each of primers from matrix gene and 10 picomoles each of primer targeting the HA gene. Rest of the conditions of PCR reaction were the same as sub-typing multiplex PCR.
Sub-typing -Multiplex PCR
A multiplex PCR was performed with 5 μl of cDNA in 25 μl reaction volume containing 200 μM of each dNTPs, 50 picomoles each of forward and reverse primers for seasonal H1, H3, N1 and N2, 1.5 U of Taq DNA polymerase. DNA amplifi cation was performed using initial denaturation for 3 min at 94°C, followed by 40 cycles of denaturation for 30 s at 94°C, annealing for 30 s at 50°C and extension for 30 s at 72°C, with fi nal extension for 10 min at 72°C in a thermocycler. Amplicon of 164, 232, 106 and 173 bp, respectively, were visualised for H1, H3, N1 and N2 [ Figure 1b ]. In addition, a multiplex RT-PCR for pandemic A (H1N1) pdm09 infl uenza viruses was also carried out on 96 samples collected after September 2009 with primers for matrix gene and HA gene giving amplicons of 348 and 465 bp, respectively [ Figure 1c ].
Results

Infl uenza detection by RT-PCR and virus isolation
During the study period, June 2007 to January 2009 and September to November 2009, 1567 clinical samples from cases with ILI were collected, of which 544 samples were randomly selected and evaluated for typing, and sub-typing of infl uenza virus by cell culture and RT-PCR [ Table 2 ]. Infl uenza viruses were detected in 136/544 (25%) samples by RT-PCR; of these, 64 (47%) were typed as infl uenza A and 47 (34.5%) as infl uenza B and in 3 (2%) samples dual infection with infl uenza A and B viruses was identifi ed. In 22/96 (22.9%) samples from September 2009 onwards pandemic A (H1N1) pdm09 infl uenza viruses were detected.
By virus isolation and HI infl uenza viruses were detected in 97 of 544 (17.8%) specimens tested; of these, 59 (43.3%) were typed as infl uenza A and 38 (27.9%) as infl uenza B and no co-infections were identifi ed [ Table 2 ]. Of the 86 infl uenza A viruses detected by RT-PCR, only 59/86 (68.6%) were positive by virus isolation, whereas 38/47 (80.8%) of infl uenza B positive specimens were detected by virus culture. Thus RT-PCR increased the detection rates of infl uenza by 28.6% as compared with virus isolation. Infl uenza viruses were detected in additional 7.1% specimens by RT-PCR.
Infl uenza A sub-typing by multiplex RT_PCR and virus isolation
Of the 64 infl uenza A positive samples, 48 (75%) were identifi ed as seasonal infl uenza A/H1N1, and 16 (25%) as A/H3N2 by mRT-PCR. In addition, in 96 samples tested by additional pdm09 m-RT-PCR, 22 (22.9%) were found positive for pandemic A (H1N1) pdm09. Comparison of infl uenza A sub-type detection by mRT-PCR and virus isolation revealed a marked difference in sub-type detection by virus isolation; whereas all of A (H1N1) pdm09 were detected by both culture and RT-PCR, only 26/48 (54%) of seasonal A/H1N1 from 2007 and 11/16 (68%) of A/H3N2 were detected by virus isolation, suggesting a lower sensitivity for seasonal infl uenza A/H1N1 viruses from 2007 to 2008 [ Table 2 ]. The sensitivity of RT-PCR as compared with virus isolation taken as gold standard was 100% but the specifi city varied between 94% and 100% and positive predicitive value (PPV) was between 54% and 100% and negative predictive value (NPV) was 100% [ Table 2 ]. Analysis of clinical features of infl uenza positive and negative indiviuals revealed that headache and body ache were associated with infl uenza positivity (P < 0.05) [ Table 3 ].
Discussion
Traditionally infl uenza virus surveillance is based on detection of infl uenza viruses by culture, although culture will remain the back bone for characterisation of circulating infl uenza viruses and vaccine strain selection, the clinical and virological surveillance can be improved by timely and accurate diagnosis. Published studies using culture methods may have under estimated the prevalence and rates of infl uenza globally. In recent years, real time RT-PCR has replaced virus isolation for infl uenza surveillance but the high cost (approximately 30 US dollars) and the non-availability of sophisticated equipment makes it less feasible for smaller laboratories in resource poor countries. Early detection of infl uenza is also important for timely detection of the fi rst cases in a community, and adoption of control measures to avoid the spread of infection in institutions and nursing homes. [10] Antiviral medications can be used as effective chemoprophylaxis to reduce the severity and duration of illness, particularly if used within the fi rst 48 h after illness onset, hence timing of viral confi rmation is important for clinical management of infl uenza. [11] In the current study, we report the comparison of conventional RT-PCR with virus isolation for detection of infl uenza viruses and found that conventional RT-PCR is a sensitive and rapid molecular technique for detection of seasonal infl uenza viruses as compared with virus isolation. In addition, we also describe an in-house mRT-PCR for the detection of pandemic A (H1N1) pdm09 infl uenza viruses. While 136/544 (25%) samples were positive for infl uenza viruses by RT-PCR, only 97/544 (17%) were positive by virus isolation; thus RT-PCR provided an increase in detection rate of approximately 28.6% as compared with virus isolation. This data is comparable to previously published studies from Scotland where 20-27% increase in detection rate using RT-PCR was reported. Further a recent study from Iran has shown 24.2% increase in detection rate by RT-PCR. [12] The lower sensitivity of detection by virus isolation may be due to the fact that culture assays need a minimum number of viable virus particles in the clinical samples, and viability is often lost between collection of specimens and execution of laboratory tests due to improper storage. [13] In these circumstances, assays that are able to detect viral nucleic acid, without requiring viable viruses, offers a great advantage. [14] An additional unique feature of the current study was the ability of mRT-PCR to rapidly sub-type infl uenza A viruses including pandemic A (H1N1) pdm09 viruses. Whereas for typing and sub-typing by HAI one has to depend upon availability of specifi c antisera usually prepared in ferrets. Further by RT-PCR co-infections with infl uenza A and B viruses could also be detected, which were missed by virus isolation. Similar fi ndings have also been reported by other studies. [15] The only few food and drug administration (FDA)-approved molecular assays for sub-typing infl uenza A viruses are the xTAG respiratory virus panel assay (Luminex Corp., Australia), which is a multiplex RT-PCR assay that uses fl ow cytometry for detection and the single plex real time RT-PCR assays developed by CDC. However, the mRT-PCR assay developed in this study can rapidly sub-type circulating human infl uenza A viruses. A Fluplex multiplex RT-PCR has also been developed by a laboratory in Milwaukee Wisconsin, USA but the confi rmation of results in this assay are based on an enzyme hybridisation technique, which further makes it more expansive and technically diffi cult. [16] Further the mRT-PCR for pandemic A (H1N1) pdm09 viruses can also be combined as a single multiplex assay to the sub-typing mRT-PCR to make this assay more economical and easy to perform. Taken together, these studies suggest that infl uenza detection by RT-PCR is much more sensitive than traditional culture methods, it has a faster turnaround time and the advantages over real time RT-PCR are that it does require high technical expertise and specialised equipment, and is cost effective. This assay should be useful in diagnostic and epidemiological settings in resource poor countries.
Conclusion
In summary, this study describes a comparison of an in-house RT-PCR with virus isolation for infl uenza viruses. RT-PCR was found to be rapid, sensitive and cost-effectiveness molecular method for diagnosis of seasonal infl uenza A and pandemic A (H1N1) pdm09 infl uenza viruses that circulate regionally and globally. Further the study demonstrated that sub-typing by multiplex RT-PCR of infl uenza viruses can be achieved rapidly, which is important for epidemiologic surveillance, and rapid identifi cation of circulating strains of infl uenza viruses. Our study demonstrates that sensitivity of virus isolation for A/H1N1 pdm09 viruses was 100% as compared to RT-PCR but seasonal infl uenza viruses were detected by RT-PCR in additional 39 samples.
